Perlmutter Cancer Center opens transplantation and cellular therapy center for blood cancers

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

The Tartu University Hospital, North Estonia Medical Centre, and Icosagen have joined forces to develop and introduce an innovative personalized cell therapy for patients in Estonia.

May 31, 2024

Vol.50 No.22

Clinical Roundup

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues.

May 24, 2024

Vol.50 No.21

Clinical Roundup

Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival

Standard of care treatment for acute myeloid leukemia is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.

May 17, 2024

Vol.50 No.20

Clinical Roundup

Lower MRD prior to HCT associated with better outcomes in FLT3-ITD AML

Patients in remission after being treated for a high-risk blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells.

May 03, 2024

Vol.50 No.18

Regulatory News

ODAC gives thumbs-up to imetelstat for MDS, upholding the value of transfusion independence

The FDA Oncologic Drugs Advisory Committee voted 12:2 to recommend approval of the drug imetelstat for a myelodysplastic syndrome indication.

March 15, 2024

Vol.50 No.11

By Jacquelyn Cobb and Paul Goldberg

In Brief

Damian Green named chief of Division of Transplantation & Cellular Therapy at Sylvester

Damian Green will join Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine this spring to lead its transplantation and cellular therapy services. Green was named chief of the Division of Transplantation & Cellular Therapy, as well as assistant director of Translational Research, beginning March 1.

February 23, 2024

Vol.50 No.08

Perlmutter Cancer Center opens transplantation and cellular therapy center for blood cancers

YOU MAY BE INTERESTED IN

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival

Lower MRD prior to HCT associated with better outcomes in FLT3-ITD AML

ODAC gives thumbs-up to imetelstat for MDS, upholding the value of transfusion independence

Damian Green named chief of Division of Transplantation & Cellular Therapy at Sylvester

Renew today!

Subscriber content

Login